Trial intelligence / Profile preview

Dexmedetomidine vs Lidocaine vs Magnesium Sulphate for Enhanced Quality of Recovery After Spine Surgery Fixation

NCT07843953Not yet recruiting

Sponsor
Zagazig University
Start
Sep 2026
Primary completion
Dec 2026
01

Overview

Randomised trial in postoperative pain comparing Group (L) LIDOCAINE, Group (D) Dexmedetomidine and Group (M) Magnesium sulphate (3 arms). Primary endpoint: Quality of Recovery-40 score. Planned start Sep 2026; status: not yet recruiting.

02

Drugs

dexmedetomidineLidocaine Hydrochloride Injection, without epinephrinemagnesium sulfate
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT07843953.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07843953.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call